Overall, Basque Country and Navarre showed an increasing trend over time in antiosteoporotic treatment after hip fracture, whereas Catalonia and the Valencia Region showed a U-shaped trend, with a steep decrease between 2011 and 2014 for Valencia and 2011–2012 for Catalonia, and a more gradual rise from 2014 onwards.
← all excerpts
Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain.
1
—
—